Bioxytran (BIXT, $0.11) was one of top quarterly gainers, jumping +1 to $0.11 per share. A.I.dvisor analyzed 857 stocks in the Biotechnology Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.